Health

Researchers Identify a Baffling New Type of Diabetes That Affects Millions

Human Body Metabolism Energy Concept

Malnutrition-related diabetes is a puzzling form of diabetes that affects tens of millions of individuals in sub-Saharan Africa and Asia.

A new study investigates a mysterious form of diabetes.

Malnutrition-related diabetes is a mysterious form of diabetes that affects tens of millions of individuals in sub-Saharan Africa and Asia. Rarely do its victims, who are mostly skinny and poor teens and young adults, survive more than a year following diagnosis. Their young age and frail appearance point to type 1 diabetes (T1D), yet insulin shots often are ineffective and may even result in low blood sugar deaths. Additionally, none of the individuals seem to have type 2 diabetes (T2D), which is often linked to obesity. Despite the fact that the illness was originally documented about 70 years ago, physicians are still unaware of how to treat it due to a lack of research on the condition.

Key Step Towards a Treatment

The founding director of Einstein’s Global Diabetes Institute, Meredith Hawkins, M.D., M.S., has led an international collaborative effort for the past 12 years to identify the underlying metabolic defects that result in malnutrition-related diabetes, which is an essential first step in developing effective treatments. Dr. Hawkins and colleagues have shown that malnutrition-related diabetes is significantly metabolically distinct from T1D and T2D and should be regarded as a distinct type of diabetes in the first thorough examination of patients with this poorly known condition. Their research was recently published in the journal Diabetes Care.

“Current scientific literature offers no guidance on managing malnutrition-related diabetes, which is rare in high-income nations but exists in more than 60 low- and middle-income countries,” said Dr. Hawkins, professor of medicine and the Harold and Muriel Block Chair in Medicine at Einstein. “The doctors in those countries read Western medical journals, so they don’t learn about malnutrition-related diabetes and don’t suspect it in their patients. We hope our findings will increase awareness of this disease, which is so devastating to so many people and will pave the way for effective treatment strategies.”

Investigating Insulin’s Role

In cooperation with Dr. Hawkins and other members of the Global Diabetes Institute, the study was carried out at the renowned Christian Medical College in Vellore, India. The researchers conducted comprehensive metabolic assessments on 20 males aged 19 to 45 who were selected as likely to develop malnutrition-related diabetes using cutting-edge methods for measuring insulin secretion and action. The same metabolic tests were performed on groups of people with T1D, T2D, and healthy controls for the sake of comparison. Males make up roughly 85% of those who acquire diabetes from malnutrition, hence the study’s subjects were exclusively male to reduce sex-specific variability.

“We used highly sophisticated techniques to rigorously and carefully study these individuals—and our conclusions differ from earlier clinical observations,” said Dr. Hawkins.

More specifically, earlier findings had suggested that malnutrition-related diabetes stemmed from insulin resistance. (The hormone insulin enables glucose in the blood to enter the body’s cells to be used for energy; in insulin resistance, glucose in the blood rises to toxic levels because cells no longer respond to a person’s own insulin.) “But it turns out,” said Dr. Hawkins, “that people with malnutrition-related diabetes have a very profound defect in insulin secretion, which wasn’t recognized before. This new finding totally revolutionizes how we think about this condition and how it should be treated.”

The good news, according to Dr. Hawkins, is that many new drugs have recently become available for treating T2D, some of which boost insulin secretion from the pancreas—raising the possibility of finding safe and effective ways of treating the condition.

“Diabetes has become a true global pandemic,” Dr. Hawkins noted. “One in 10 adults worldwide has the disease, and three-quarters of them—some 400 million people—live in low- and middle-income countries,” she said. “In those countries where it’s been studied, the prevalence of malnutrition-related diabetes among people with diabetes is about 20%, meaning that about 80 million people may be affected worldwide. For comparison, an estimated 38 million people are now living with HIV/AIDS. So we clearly need to learn a lot more about malnutrition-related diabetes and how best to treat it.”

Reference: “An Atypical Form of Diabetes Among Individuals With Low BMI” by Eric Lontchi-Yimagou, Riddhi Dasgupta, Shajith Anoop, Sylvia Kehlenbrink, Sudha Koppaka, Akankasha Goyal, Padmanaban Venkatesan, Roshan Livingstone, Kenny Ye, Aaron Chapla, Michelle Carey, Arun Jose, Grace Rebekah, Anneka Wickramanayake, Mini Joseph, Priyanka Mathias, Anjali Manavalan, Mathews Edatharayil Kurian, Mercy Inbakumari, Flory Christina, Daniel Stein, Nihal Thomas and Meredith Hawkins, 27 May 2022, Diabetes Care.
DOI: 10.2337/dc21-1957

Share

View Comments

  • Then there's the other, less mentioned cause of diabetes... the type that is caused by steroid-based medications that doctors seem to be at a complete loss to diagnose, even when their patients tell them, and the medical records show that they are taking such medications for chronic health conditions like asthma.

    This is an entirely preventable type of diabetes that is accompanied by a long list of other nasty side effects and our GPS seem to be utterly incapable (or willfully neglectful) in preventing it.

    • Theym won't accept that their own existence is real unless their was a peer-reviewed study.
      All professionals (not just physicians) think too much and experience too little.

  • This is interesting. I wonder if the body is shutting down the pancreas in an ill-fated attempt to preserve calories, in the setting of near starvation. While it's good that the new diabetes medications might be an effective treatment, I don't know if it will matter in impoverished regions where access to those medications would be limited, at best. Wouldn't the better approach be to address the cause - malnutrition - to prevent the disease, rather than focusing on managing it, after the fact? New medications are prohibitively expensive. Perhaps, we should study the effects on health of providing food to impoverished people.

By
Albert Einstein College of Medicine

Recent Posts

Dinosaur-Killing Asteroid Triggered Monstrous Global Tsunami With Mile-High Waves

Sixty-six million years ago a miles-wide asteroid struck Earth, wiping out nearly all the dinosaurs…

October 5, 2022

NASA, SpaceX Proceeding to Crew-5 Launch to International Space Station

NASA will provide live coverage of the upcoming launch activities for the SpaceX Crew-5 mission…

October 5, 2022

Even Moderate Exercise Can Greatly Increase Brain Size

The effects are more pronounced in brain areas with high oxygen demand. Exercise keeps both…

October 4, 2022

Caltech’s Breakthrough New Nanophotonic Chip “Squeezes” More Out of Light

Electronic computing and communications have advanced significantly since the days of radio telegraphy and vacuum…

October 4, 2022

Parallels to HIV: Another Fatal Monkey Virus Could Be Poised for Spillover to Humans

Evoking parallels to HIV, authors are calling on global health community to be vigilant. According…

October 4, 2022

Scientists Show Transmission of Epigenetic Memory Across Multiple Generations

Changing the epigenetic marks on chromosomes results in altered gene expression in offspring and in…

October 4, 2022